137 related articles for article (PubMed ID: 15826816)
1. Treatment of mice with IL-12 DNA constructs leads to augmented NK activity in lungs but low IFN-gamma release -- implications for Bordetella pertussis infections following aerosol challenge.
Carter CR; Dagg BM; Whitmore KM; Keeble JR; Asokanathan C; Rodgers A; Watanabe M; Xing D; Walker KB
Cytokine; 2005 May; 30(3):100-8. PubMed ID: 15826816
[TBL] [Abstract][Full Text] [Related]
2. High dose interleukin-12 exacerbates Bordetella pertussis infection and is associated with suppression of cell-mediated immunity in a murine aerosol challenge model.
Carter CR; Dagg BM; Whitmore KM; Keeble JR; Asokanathan C; Xing D; Walker KB
Clin Exp Immunol; 2004 Feb; 135(2):233-9. PubMed ID: 14738450
[TBL] [Abstract][Full Text] [Related]
3. Depletion of NK cells results in disseminating lethal infection with Bordetella pertussis associated with a reduction of antigen-specific Th1 and enhancement of Th2, but not Tr1 cells.
Byrne P; McGuirk P; Todryk S; Mills KH
Eur J Immunol; 2004 Sep; 34(9):2579-88. PubMed ID: 15307190
[TBL] [Abstract][Full Text] [Related]
4. Lung pathology and immediate hypersensitivity in a mouse model after vaccination with pertussis vaccines and challenge with Bordetella pertussis.
Vandebriel RJ; Gremmer ER; Vermeulen JP; Hellwig SM; Dormans JA; Roholl PJ; Mooi FR
Vaccine; 2007 Mar; 25(12):2346-60. PubMed ID: 17224216
[TBL] [Abstract][Full Text] [Related]
5. The effect of pertussis whole cell and acellular vaccines on pulmonary immunology in an aerosol challenge model.
Carter CR; Dagg BM; Whitmore KM; Keeble JR; Asokanathan C; Xing D; Walker KB
Cell Immunol; 2004 Jan; 227(1):51-8. PubMed ID: 15051514
[TBL] [Abstract][Full Text] [Related]
6. Lipopolysaccharide analogs improve efficacy of acellular pertussis vaccine and reduce type I hypersensitivity in mice.
Geurtsen J; Banus HA; Gremmer ER; Ferguson H; de la Fonteyne-Blankestijn LJ; Vermeulen JP; Dormans JA; Tommassen J; van der Ley P; Mooi FR; Vandebriel RJ
Clin Vaccine Immunol; 2007 Jul; 14(7):821-9. PubMed ID: 17494641
[TBL] [Abstract][Full Text] [Related]
7. CD11c+CD8alpha+ dendritic cells promote protective immunity to respiratory infection with Bordetella pertussis.
Dunne PJ; Moran B; Cummins RC; Mills KH
J Immunol; 2009 Jul; 183(1):400-10. PubMed ID: 19542451
[TBL] [Abstract][Full Text] [Related]
8. The cellular immune response to Bordetella pertussis in two children with whooping cough.
Hafler JP; Pohl-Koppe A
Eur J Med Res; 1998 Nov; 3(11):523-6. PubMed ID: 9810032
[TBL] [Abstract][Full Text] [Related]
9. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H
Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645
[TBL] [Abstract][Full Text] [Related]
10. [Novel vaccines against M. tuberculosis].
Okada M
Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
[TBL] [Abstract][Full Text] [Related]
11. IL-12 cDNA direct injection: antimetastatic effect from a single injection in a murine hepatic metastases model.
Weber SM; Qi C; Neal Z; Sondel P; Mahvi DM
J Surg Res; 2004 Dec; 122(2):210-7. PubMed ID: 15555620
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of the whole-cell pertussis vaccine produced in Poland against different Bordetella parapertussis isolates in the mouse intranasal challenge model.
Zawadka M; Polak M; Rabczenko D; Mosiej E; Augustynowicz E; Lutyńska A
Vaccine; 2011 Jul; 29(33):5488-94. PubMed ID: 21641954
[TBL] [Abstract][Full Text] [Related]
13. Direct anti-inflammatory effect of a bacterial virulence factor: IL-10-dependent suppression of IL-12 production by filamentous hemagglutinin from Bordetella pertussis.
McGuirk P; Mills KH
Eur J Immunol; 2000 Feb; 30(2):415-22. PubMed ID: 10671196
[TBL] [Abstract][Full Text] [Related]
14. Age-dependent natural killer cell and interferon γ deficits contribute to severe pertussis in infant mice.
Mitchell AE; Scanlon KM; Flowers EM; Jordan CM; Tibbs EJ; Bukowski A; Gallop D; Carbonetti NH
J Leukoc Biol; 2024 May; 115(6):1143-1153. PubMed ID: 38285898
[TBL] [Abstract][Full Text] [Related]
15. Differences in innate IFNγ and IL-17 responses to Bordetella pertussis between BALB/c and C57BL/6 mice: role of γδT cells, NK cells, and dendritic cells.
Mosley YC; Lu F; HogenEsch H
Immunol Res; 2017 Dec; 65(6):1139-1149. PubMed ID: 29052125
[TBL] [Abstract][Full Text] [Related]
16. Laboratory investigation of immune responses to acellular pertussis vaccines when used for boosting adolescents after primary immunisation with whole cell pertussis vaccines: a comparison with data from clinical study.
Reynolds E; Walker B; Xing D; Southern J; Asokanathan C; Dagg B; Corbel M; Miller E
Vaccine; 2006 Apr; 24(16):3248-57. PubMed ID: 16480794
[TBL] [Abstract][Full Text] [Related]
17. Acellular Bordetella pertussis vaccine enhances mucosal interleukin-10 production, induces apoptosis of activated Th1 cells and attenuates colitis in Galphai2-deficient mice.
Ohman L; Willén R; Hultgren OH; Hultgren Hörnquist E
Clin Exp Immunol; 2005 Jul; 141(1):37-46. PubMed ID: 15958068
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-12 is produced by macrophages in response to live or killed Bordetella pertussis and enhances the efficacy of an acellular pertussis vaccine by promoting induction of Th1 cells.
Mahon BP; Ryan MS; Griffin F; Mills KH
Infect Immun; 1996 Dec; 64(12):5295-301. PubMed ID: 8945580
[TBL] [Abstract][Full Text] [Related]
19. The pro-Th2 cytokine IL-33 directly interacts with invariant NKT and NK cells to induce IFN-gamma production.
Bourgeois E; Van LP; Samson M; Diem S; Barra A; Roga S; Gombert JM; Schneider E; Dy M; Gourdy P; Girard JP; Herbelin A
Eur J Immunol; 2009 Apr; 39(4):1046-55. PubMed ID: 19266498
[TBL] [Abstract][Full Text] [Related]
20. Mucosal immunisation of murine neonates using whole cell and acellular Pertussis vaccines.
Hale C; Humphreys IR; Hussell T; Bowe F; Clare S; Pickard D; Preston A; Del Giudice G; Dougan G
Vaccine; 2004 Sep; 22(27-28):3595-602. PubMed ID: 15315838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
